N04BD02 • rasagiline • Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors
Rasagiline is a medication used to treat Parkinson's disease, a neurodegenerative condition characterized by tremors, rigidity, and movement difficulties. It is a selective monoamine oxidase type B (MAO-B) inhibitor that increases dopamine levels in the brain, thereby alleviating symptoms of the disease.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and avoid tyramine-rich foods, such as aged cheeses, to prevent adverse reactions.
Side effects may include headache, dizziness, nausea, or insomnia. In rare cases, severe adverse effects such as high blood pressure or allergic reactions may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as depression or hypertension, to ensure the safe use of rasagiline.
Substance: rasagiline
Date of last drug list: 01-03-2017
Commercial code: W63045001
Concentration: 1mg
Pharmaceutical form: tablets
Quantity: 7
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).